上周,辉瑞报告其新冠疫苗Comirnaty第三季度销售额为14亿美元,同比增长9%。前几天,BioNTech也披露其新冠疫苗第三季度销售额为12.4亿欧元(约合13.5亿美元),这一数字是市场普遍预期的6.52亿美元的两倍多。 在电话会议上,Moderna首席执行官Stephane ...
上周,辉瑞报告其新冠疫苗Comirnaty第三季度销售额为14亿美元,同比增长9%。前几天,BioNTech也披露其新冠疫苗第三季度销售额为12.4亿欧元(约合13.5亿美元),这一数字是市场普遍预期的6.52亿美元的两倍多。 在电话会议上,Moderna首席执行官Stephane Bancel表示,美国食品药品监督管理局(FDA)比2023年提前19天批准了该疫苗...
A new report accuses American drugmaker Moderna of prioritizing profits from COVID-19 vaccines by keeping poor countries waiting. The New York Times says the vaccine maker has sold most of its doses to wealthier nations. Only one million doses have gone to low-income countries...
近日,美国食品药品监督管理局(FDA)和疾病控制与预防中心(CDC)指控Moderna在其二价新冠疫苗的批准过程中隐瞒数据。FDA和CDC多名顾问表示:“对Moderna的这一行为表示愤怒和失望!为了获得纳税人的50亿美元订单,Moderna隐瞒了接种二价疫苗的研究参与者中有3.2%被感染,而接受一价疫苗的参与者中只有1.9%被感染的事实数据。...
WASHINGTON - Drugmaker Moderna asked the Food and Drug Administration on Thursday to authorize a fourth shot of its COVID-19 vaccine as a booster dose for all adults.The request is broader than rival pharmaceutical company Pfizer's request earlier this week for the regulator to approve a...
[1]https://www.dailymail.co.uk/health/article-11624959/FDA-CDC-vaccine-advisers-angry-early-data-Covid-19-booster-shot-withheld-year.html [2]Chalkias S, Eder F, Essink B,et al. Safety, immunogenicity and antibody persistence of a bivalent Beta-containing booster vaccine against COVID-19...
Moderna says its COVID-19 vaccine strongly protects kids as young as 12. The company released the preliminary findings Tuesday based on testing on more than 3,700 12- to 17-year-olds in the United States.
Moderna aims to roll out a combined COVID-flu-RSV booster vaccine in late 2023, the US pharmaceutical firm said Monday, hoping a joint jab would encourage people to get an annual shot. The single vaccine for COVID-19, influenza andrespiratory syncytial virus—a common virus that causes the...
Moderna is gearing up to halve the dose of its COVID-19 vaccine, the US drugmaker said on Wednesday, so that it can also be used to combat variants and inoculate children. It has agreed a deal with Swiss-based drugmaker Lonza which said a new drug substance production line in Geleen,...
December 16 2023 Lex Moderna: good news on skin cancer vaccine is welcome distraction from Covid-19 shot sales woes Premium content US biotech company’s stock worth nearly $500 at its peak in August 2021, currently trades at less than $87 Save December 5 2023 Legal services Standout ...